Walker Luke Nathaniel
SEC CIK 1701440 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | Dir | 201.4K | $25.0K | — | 4 | 2024-05-24 | 2026-06-16 |
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
| 11 | Walker Luke Nathaniel | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 16:07 | 2026-06-16 | ZNTL | Zentalis Pharmaceuticals, Inc. | Walker Luke Nathaniel | Dir | A - Grant | $0.00 | +57.1K | 201.4K | +40% | $0 | |
| 2025-06-18 | 2025-06-17 | ZNTL | Zentalis Pharmaceuticals, Inc. | Walker Luke Nathaniel | Dir | A - Grant | $0.00 | +57.6K | 144.3K | +66% | $0 | |
| 2025-02-04 | 2025-01-31 | ZNTL | Zentalis Pharmaceuticals, Inc. | Walker Luke Nathaniel | Dir | P - Purchase | $1.76 | +14.2K | 86.7K | +20% | +$25.0K | |
| 2024-05-29 | 2024-05-24 | ZNTL | Zentalis Pharmaceuticals, Inc. | Walker Luke Nathaniel | Dir | A - Grant | $0.00 | +72.5K | 72.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations